Active Ingredient: DAPSONE
Proprietary Name: DAPSONE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A204074
Product Number: 002
Approval Date: May 10, 2016
Applicant Holder Full Name: CHARTWELL RX SCIENCES LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information
